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Decisions of Value: Going Backstage 3 
&RPPHQWRQ³&RQWH[WXDO)DFWRUV,QIOXHQFLQJ&RVWand Quality Decisions in Health and Care: 4 
$6WUXFWXUHG(YLGHQFH5HYLHZDQG1DUUDWLYH6\QWKHVLV´ 5 
Michael Calnan 6 
Abstract 7 
This commentary expands on two of the key themes briefly raised in the paper involving 8 
analysis of the evidence about key contextual influences on decisions of value. The first theme 9 
focuses on the need  to explore in more detail  what is called backstage decision-making looking 10 
at how actual decisions are made drawing on evidence from ethnographies about decision-11 
making. These studies point to less of an emphasis on instrumental and calculative forms of 12 
decision-making with more of an emphasis on more pragmatic rationality. The second related 13 
theme picks up on the issue of sources of information as a contextual influence particularly 14 
highlighting the salience of uncertainty or information deficits. It is argued that there are a 15 
range of different types of uncertainties, not only associated with information deficits, which 16 
are found particularly in allocative types of decisions of value. This means that the decision-17 
making process although attempting to be linear and rational, tends to be characterised by a 18 
form of navigation where the decision-makers navigate their way through the uncertainties 19 
inherent and overtly manifested in the decision-making process 20 
Keywords: Context, Uncertainty, Allocative decisions 21 
The importance of understanding the contextual influences on decision-making about cost and 22 
quality related questions in the organisation and provision of health care is well recognised1. 23 
However, this paper2 goes one stage further by carrying out a structured evidence review and 24 
narrative synthesis trying to identify the evidence from the international available literature 25 
about the key contextual influences. A distinction is made between allocative and technical 26 
types of decisions of value with the bulk of evidence being found in relation to the former 27 
rather than the latter type of decision making. The analysis, drawing on the framework provided 28 
by Pettigrew3, identifies a number of inner and outer contextual influences on what the authors 29 
call µdecisions of value¶.  In terms of the contextual influences these are categorised in terms 30 
2 
 
of sources of information; interests; organisational characteristics, governance and leadership, 1 
geography, economics and relationship to government. The focus is at the meso level, as 2 
opposed to the micro-and macro levels, and on more formal aspects of decision-making. 3 
The paper provides a useful presentation of the state of the evidence about contextual 4 
influences but tends to pay limited attention to what might be called backstage4 as opposed to 5 
front stage decision-making. This is alluded to in the paper but it is central to understanding 6 
how decisions get made. For example, in the area of priority setting these decision- making 7 
processes have been described, at least some time ago , DVµPXGGOLQJWKURXJKHOHJDQWO\¶ZKHUH8 
there is more evidence of negotiation rather than rationality or instrumentality in decision-9 
making 5 This type of decision-making process is messy and non-linear, and in spite of apparent 10 
significant changes in the quality of evidence available and the sophistication of techniques 11 
used to analyse these data, has still been found at different levels of decision-making in the 12 
public funded national health service in England. For example, research focusing at the national  13 
level involving the µfourth¶ stage of medicine regulation and which has explored decision-14 
making by NICE about the appraisal of expensive medicines has identified the difference 15 
between front stage and backstage decision-making. The discourse associated with front stage 16 
decision-making emphasises the dominant influence of the technical criteria of cost-17 
effectiveness although in some cases social values tended to receive some explicit recognition 18 
in the decision making such as in the treatment for younger children. The attempt to explicitly 19 
incorporate social and ethical YDOXHVZDVVKDSHGE\DQDSSURDFKGHVFULEHGDVµDFFRXQWDELOLW\20 
for reasonaEOHQHVV¶ which emphasised the conditions of transparency, relevance and 21 
revisabilty6. EYLGHQFHDERXWWKHLPSOHPHQWDWLRQRISROLFLHVLQVRPHFRXQWULHVEDVHGRQWKLV¶22 
DFFRXQWDELOLW\ IRU UHDVRQDEOHQHVV¶ DSSURDFK LV DYDLODEOH7. However, this evidence tends to 23 
focus on decision-making at the formal level and the research evidence from ethnographic 24 
studies involving interviews, documentary analysis and observation points suggests that while 25 
the discourse particularly on cost-effectiveness did generally frame the approach taken  a less 26 
than rational or calculative approach in the backstage decision-making was prevalent.. This 27 
research identifies the implicit social influences about how decisions are made and suggest that 28 
the decision-making process is characterised by a form of navigationUDWKHUWKDQµPXGGOLQJ29 
WKURXJK¶) where the decision-makers navigate their way through the uncertainties inherent in 30 
what is formally described as evidence-based decision making process.8 The paper suggests 31 
that ¶FRVW HIIHFWLYHQHVV DQDO\VLV ZKLFK KDV EHHQ DSSOLHG ZLWK VRPH VXFFHVV WR DOORFDWLYH32 
decision-making at a macro level.2.p¶The evidence from ethnographic studies9 suggest that 33 
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this account may only present a partial picture of the nature of the decision-making process and 1 
what shapes it.  2 
Similarly at the more local  level decisions about the commissioning might also be 3 
characterised as practical rationality and involve intuition and experiential knowledge 9and a 4 
µFDVHDQGMXGJHPHQWEDVHG¶approach.10 In both these national and local level contexts the use 5 
of practical rationality is evident but appeared to complement the dominant instrumental 6 
discourse, although in the local context emphasis in the discussion on ethical issues in relation 7 
to the allocation of resources was not only more overt  but related more directly to individual 8 
circumstances.  9 
A related issue is the question of sources of information which is identified as one of the key 10 
contextual elements. The paper LGHQWLILHVWKHLPSRUWDQFHRIWKHDEVHQFHRILQIRUPDWLRQµhigh 11 
levels of uncertainty in the face of information deficits have been shown to reduce adherence 12 
to an instrumental decision-making model and to open up determinations to greater levels of 13 
judgemenWDQG LQWXLWLRQ¶p9¶2.Thus, there is recognition of the salience of uncertainty in the 14 
context of these decision-making and the implications for rational decision-making. However, 15 
studies have shown that in allocative decision-making there are different types of uncertainties 16 
not only associated with information deficits and these will need to be recognised and be 17 
managed if a decision is to be made. Three different types of uncertainty have  been identified  18 
which are interrelated in the decision-making process11 which were  epistemic (referring to the 19 
ability of biomedical methods used by the pharmaceutical industry to produce knowledge about 20 
treatments), procedural (particularly relating to the sheer volume of evidence considered), and 21 
interpersonal which (refers to the competency and motives of those providing evidence such 22 
as the representatives from the pharmaceutical industry and clinical experts). There was also 23 
uncertainty and ambiguity associated with the level of technicality and complexity of the 24 
information provided8. Agencies such as NICE recognise, attempt to address and try to resolve 25 
some of these epistemological uncertainties particularly through quantitative techniques12. 26 
However, the evidence8also suggested that navigation of these layers of uncertainty was 27 
(partially) managed through practical rationality and various forms of trust at different levels. 28 
Trust was one of a number of means used to bridge uncertainty. Both individual decision as 29 
rules of thumb and collective strategies were evident in the management of uncertainty in the 30 
decision-making process. Thus, though seemingly an objective techno-scientific evaluation, 31 
social forces necessarily emerge in the development and subsequent management of 32 
uncertainty 8. 33 
4 
 
There is some disagreement over how these uncertainties should be tackled although there is 1 
consensus that they should be recognised and acknowledged rather than ignored and being 2 
bracketed off. However, while one approach tends to want to minimise them as they are seen 3 
as a problem 13whereas the other see uncertainty more positively as a way of making rationing 4 
decisions more transparent, accountable and democratic14.  5 
The review paper2 identifies the significance of external and internal interests but says little 6 
about the key role of commercial interests in influencing decision-making even though some 7 
appear to have been identified in the papers reviewed. It might be argued that the profit motive 8 
which might be the primary driver of these commercial interest groups which could be at odds 9 
with the public interest and the professional values of those providing the health care. This 10 
would include the influence of corporate private companies who finance and provide health 11 
care and of the multi-national pharmaceutical industry.  For example, the study8 previously 12 
described also illustrated the potential risks of regulatory capture15,16 of NICE in England by 13 
the pharmaceutical industry although there are both formal and informal mechanisms to 14 
attempt to manage and resist their influence. In this case the pharmaceutical industry might be 15 
characterised as both an external and internal contextual influence given that it contributes to 16 
the process by providing and controlling access to evidence about cost effectiveness but is not 17 
directly involved in the decision making.  18 
More generally, the organising framework developed by Pettigrew3 based on an organisation 19 
outside of health system in the industrial sector is used to analyse the difference between 20 
external and internal contextual influences. It must be emphasised that this framework relates 21 
primarily to health systems in high income countries and tends to focus on, although not 22 
explicitly stated, organisational and political influences rather than cultural context17,18. This is 23 
a useful descriptive schema for categorising and classification but as the authors suggest it is a 24 
framework mainly used for analysing change processes rather than explaining the relative 25 
importance of different layers of contextual influence. Certainly, it is difficult to assess the 26 
explanatory power of the framework given that it was not specifically designed for this 27 
particular purpose. One area that needs to be discussed in more depth is the dynamic nature of 28 
the decision-making process and the interrelationship between the different layers of the 29 
influence. These may be at the macro, meso and micro levels and the question is which are the 30 
most powerful contextual influences? Alternative theoretical approaches such as the structural 31 
interest approach of Alford 19 might shed more light on this. The paper proposes2 that the 32 
evidence suggests that internal influences appear to be more powerful although much depends 33 
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upon the latitude available to local actors in their decision making. Local managers and 1 
clinicians, at least in the NHS in England, tend to have some degree of relative autonomy and 2 
discretion but it has been suggested that the interplay between corporate monopolisers and 3 
professional rationalisers 19,20 might shape the decision-making process in many health care 4 
organisational settings which in turn could limit in particular the influence of bottom-up 5 
pressures. 6 
The influence of bottom up pressures is raised in the paper 2 through discussion of the role of the 7 
patients in decision-making and the importance of hearing the patient voice. This should certainly 8 
help democratise health services and mitigate against the dominance of managerial and professional 9 
interests as well enhance patient centred care and the coproduction of knowledge 14 However, it has 10 
proved difficult sometimes to square specific patients interests with more general decisions about 11 
the allocation of resources and disinvestment decisions ie what benefits the specific patient group 12 
may not be beneficial for the population as a whole.21,22 13 
Finally, from a methodological point of view the studies discussed here have tended to adopt 14 
ethnographic designs although those reviewed in the paper seem to be short on the use of this type 15 
of methodology involving observation to directly understand how and why decisions are made in 16 
everyday contexts. The lack of such studies creates considerable limitations for gaining insights into 17 
understanding the nature of decision-making and its evidence base. 18 
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